← Open Payments lookup

GABRIEL SCHWARTZ: Open Payments

NPI 1598148173 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$21,010 in 33 payments from 3 companies in 2025. Trend: 2023 $34,847 · 2024 $57,896 · 2025 $21,010

Speaker / faculty: $15,540Travel & lodging: $2,920Consulting: $1,640Food & beverage: $910
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.10$8,090
AstraZeneca Pharmaceuticals LP15$7,266
Incyte Corporation8$5,654

Products named: FRUZAQLA, Pemazyre.

Industry payments across CA — which companies pay providers there.